China's Food-Medicine Supplements Market: H1 2024 Overview

Executive Summary

China's food-medicine homology market reached CN¥ 36.61 billion in revenue on Taobao/Tmall (淘宝天猫) in the moving annual total through April 2024 (MAT2024), a -6.5% year-on-year decline even as unit sales volumes rose to 470 million units (+2.2% YoY). The divergence between falling revenue and growing volumes exposes a market under sustained pricing pressure — yet within this challenging aggregate, high-growth ingredient tracks such as poria (+54.2% YoY) and honeysuckle (+103.9% YoY) demonstrate that substantial category opportunities remain for brands willing to move beyond commoditized incumbents. This analysis examines market structure, consumer demographics, competitive dynamics, and the ingredient landscape shaping China's food-medicine supplements market in H1 2024.

Market Size and Structure

China's food-medicine homology market is navigating a structural inflection point that separates its long-run growth story from near-term competitive challenges. The CN¥ 588.5 billion e-commerce health market^[1] provides the macroeconomic context: despite Taobao/Tmall revenue contraction, broader industry fundamentals remain compelling, with the nutritional health food market projected to surpass CN¥ 800 billion by 2027. The immediate challenge is that average product prices fell from CN¥ 87.3 per unit in MAT2023 to CN¥ 79.2 in MAT2024 — a -9.3% decline reflecting intensifying price competition and platform migration by smaller merchants.

The three-year revenue trajectory — CN¥ 38.89 billion in MAT2022, CN¥ 39.17 billion in MAT2023 (+0.7% YoY), and CN¥ 36.61 billion in MAT2024 (-6.5% YoY) — confirms the market is in a pricing consolidation phase, not a demand-side contraction. The number of active sellers fell from 12.18 million in MAT2023 to 11.08 million in MAT2024, while SKU count grew from 145.39 thousand to 158.35 thousand: mid-tier and above brands are broadening portfolios while smaller merchants exit toward Douyin (抖音) or Pinduoduo (拼多多). November consistently generates the highest monthly revenues, driven by the Double 11 (双十一) shopping festival at 50-80% above the monthly baseline — a critical planning window for brands.

Consumer Demographics: A Market Broadening Its Base

The most consequential shift in the food-medicine homology market is demographic, and it contradicts long-standing assumptions about who buys these products. Male consumers now account for 56.1% of the social media food-medicine homology audience in MAT2024, up from 43.3% in MAT2023 — a 12.8 percentage point swing consistent with rising male health consciousness and short-video content framing tonic consumption in masculine health terms rather than traditional female beauty contexts. Youth engagement is simultaneously accelerating: the proportion of consumers aged 35 and under rose by 4.2 percentage points, with the 21-25 and 26-30 cohorts posting the sharpest gains, while the 50+ group remains the single largest cohort at 20.6%.

Geographically, demand is diffusing beyond China's major metropolitan centers. Tier 1 cities declined from 42.7% to 40.3% of social media discussion share, while new Tier 1 cities expanded from 20.7% to 23.1%, and Tier 2 and Tier 3 cities grew their combined share from 22.4% to 23.8%. For brands, this geographic diffusion signals an opportunity to develop accessible-premium product lines — wellness teas, ready-to-eat snack formats, and entry-price gift sets — that maintain functional and heritage appeal while meeting the budget realities of lower-tier city consumers.

The practical implication for product developers is a bifurcated strategy:

• Premium heritage tonics targeting the 50+ cohort and the male gifting occasion
• Ready-to-consume modern formats in convenient packaging for the 21-35 urban cohort
• Functional benefit messaging grounded in modern wellness language for younger consumers
• Distribution and pricing architecture calibrated for Tier 2 and Tier 3 city expansion

Ingredient Landscape: Growth Pockets in a Contracting Market

The top 20 food-medicine homology ingredients on Taobao/Tmall reveal a highly stratified competitive structure where revenue scale and growth momentum frequently point in opposite directions. Bird's nest (燕窝) leads by revenue with CN¥ 4.58 billion in MAT2023 baseline revenue, but its near-flat performance contrasts sharply with the extraordinary growth rates of smaller ingredients benefiting from consumer health trend tailwinds.

Poria (茯苓) posted the highest YoY growth among the top 20 ingredients at +54.2%, driven by growing consumer awareness of its multi-functional tonic properties including spleen nourishment, calming effects, and immune support. Honeysuckle (金银花) grew +103.9% — remarkable expansion driven by rising demand for anti-inflammatory and immunity-boosting ingredients in functional teas and compound formulations. Sea buckthorn (沙棘) expanded +31.6%, reflecting growing consumer interest in its antioxidant, digestive, and cardiovascular benefits among social media-influenced younger urban consumers.

By contrast, traditional luxury tonics are experiencing structural challenge. Ginseng (人参) declined -59.8% — one of the most dramatic reversals for an iconic category ingredient. Wellness pills fell -53.1%, and dendrobium (石斛) declined -24.8%. These contractions reflect both price sensitivity in the high-end segment and a migration of consumer interest toward functional formats that deliver specific health outcomes in modern, convenient product experiences rather than traditional tonic presentations.

Regulatory catalysts are reshaping the landscape in real time: the November 2023 National Health Commission decision to add reishi mushroom (灵芝) to the food-medicine homology directory triggered +653.4% YoY growth in the liver-protection segment in MAT2024, demonstrating that brands positioned ahead of regulatory additions capture compounding first-mover advantages.

Purchase Motivations and Consumer Occasions

Three purchase motivations dominate among consumers of dietary therapy and tonic products: boosting immunity (20%), nourishing the spleen and stomach (14%), and replenishing qi and blood (13%)^[2]. These functional priorities reflect the traditional Chinese medicine framework underpinning the food-medicine homology concept — the idea that regular consumption of the right ingredients maintains physiological balance and prevents disease. Brands that anchor their messaging to these specific functional motivations consistently outperform those relying on generic wellness claims.

The gifting occasion remains one of the most resilient revenue drivers in the category. Gift set products outperformed the overall market in MAT2024, with revenue growing +6.0% YoY and volume rising +27.7% YoY against a backdrop of overall market revenue contraction. The cultural embeddedness of tonic gifting — for Chinese New Year, for meeting a partner's parents, for postpartum recovery — insulates the premium gift segment from the price competition dynamics affecting everyday purchase transactions.

The ready-to-eat trend is simultaneously expanding the category's consumption occasions beyond special gifting moments. Social media discussion of "ready-to-eat tonic products" grew +527.4% YoY in MAT2023 and a further +155.7% YoY in MAT2024, confirming sustained compound growth in consumer interest in portable, no-preparation wellness formats. This trend is not a dilution of the category's health proposition — it is an expansion of when and how consumers can incorporate tonic ingredients into daily life.

Key Takeaways

• China's food-medicine homology market reached CN¥ 36.61 billion on Taobao/Tmall in MAT2024 (-6.5% YoY revenue, +2.2% YoY volume), signaling pricing pressure rather than demand contraction
• Male consumers reversed the gender split to 56.1% of the social media audience in MAT2024, up from 43.3% in MAT2023, demanding product repositioning toward male health priorities
• Poria (+54.2% YoY) and honeysuckle (+103.9% YoY) lead growth among the top 20 ingredients, identifying them as high-momentum category tracks within the broader market
• Regulatory catalysts — such as the November 2023 reishi mushroom directory addition — can unlock rapid commercial expansion in specific functional segments
• Gift set products (+6.0% revenue YoY, +27.7% volume YoY) and the ready-to-eat format trend (+155.7% social media discussion YoY) are the two most resilient growth vectors in the current market environment

About the Data

This analysis draws on Moojing Market Intelligence (魔镜洞察) data covering MAT2024 (May 2023–April 2024). Moojing tracks 400,000+ brands across 30+ e-commerce platforms, representing 58-65% of China's online retail GMV. Social media listening data covers Douyin (抖音), Xiaohongshu (小红书), Weibo (微博), and related content platforms. For full methodology and additional insights, see the complete H1 2024 Food-Medicine Supplements whitepaper.

For inquiries: [email protected] | moojing-global.com

^[1] China National Health Commission, "National Nutrition Plan 2017-2030"; market scale figures from China Health Industry Development Report 2024.

^[2] Moojing Market Intelligence, consumer motivation survey data for dietary therapy and tonic product category, MAT2024.